Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Tuesday said its experimental weight loss injection helped patients with obesity lose up to 20% of their weight on average after a year in a critical mid-stage trial, as the company races…
Read More “Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau” »